Zhongshan Hospital Of Traditional Chinese Medicine
15
7
7
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
13%
2 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients With Cardiovascular Disease: CPET Evaluation and Five-Year Prognostic Follow-Up Based on a Multicenter Structured Data Platform
Role: collaborator
Effect of Remimazolam With Protocolized Sedation on Critical Ill, Mechanical Ventilated Patients Compared With Midazolam
Role: collaborator
Safety and Efficacy of Ventricular Irrigation for Ventriculitis
Role: collaborator
The Effect of HIIT, MICT in Patients With Myocardial Infarction
Role: collaborator
Chinese Real-world Study of Treatment of Vestibular Migraine
Role: collaborator
Erector Spinae Plane Block Improves Organ Dysfunction in Septic Patients With Acute Gastrointestinal Injury
Role: collaborator
China Headache and Vertigo Registry Study
Role: collaborator
International Headache Registry Study
Role: collaborator
Thrombus Aspiration in STEMI Patients With High Thrombus Burden
Role: collaborator
Pipeline Embolization for Intracranial Aneurysms
Role: collaborator
Treatment of Unruptured Intracranial Aneurysms in China
Role: collaborator
Different Administration Routes of Dexmedetomidine on Postoperative Delirium
Role: collaborator
Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Role: collaborator
Xingnaojing for Moderate-to-severe Acute Ischemic Stroke (XMAS)
Role: collaborator
The Secondary Prevention Trial for Ischemic Stroke With DengzhanShengmai Capsule
Role: collaborator
All 15 trials loaded